Venous thromboembolism controversies

Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is one of the leading preventable cardiovascular diseases in the United States (US) with approximately 350,000 new cases each year.1 Even though most VTE cases are preventable, VTE episodes are still responsible for approximately 300,000 deaths per year in the US.2 When talking about VTE, we often face 3 major inquires in practice: When to treat DVT in order to prevent PE? When should direct oral anticoagulants (DOAC) be used? When to use thromboprophylaxis in the outpatient setting? Therefore, we will focus on reviewing those topics in detail, as they represent very commonly faced scenarios in the clinical practice and have very important repercussions in healthcare.
Source: Disease a Month - Category: Infectious Diseases Authors: Source Type: research